Time-Trends in Hospitalizations with Cannabis Use Disorder: A 17-Year U.S. National Study
Time-Trends in Hospitalizations with Cannabis Use Disorder: A 17-Year U.S. National Study
复制标题
大麻使用障碍住院时间趋势：一项为期 17 年的美国全国研究
DOI：
10.1080/08897077.2021.1944956
复制
发表时间：
2021
期刊：
影响因子：
3.5
通讯作者：
J. Singh
中科院分区：
文献类型：
--
作者：
J. Singh
目的：评估大麻使用障碍（滥用或依赖）住院人数是否随着时间的推移而增加，并检查与大麻使用障碍住院结果相关的变量。方法：本研究使用 1998 年至 2014 年美国全国住院患者样本数据，考察了大麻使用障碍住院率和相关医疗保健利用率。调整后的逻辑回归分析评估了大麻使用障碍住院期间人口统计、合并症和医院特征与医疗保健利用率（住院总费用、住院时间、出院到非家庭环境）之间的关联。计算优势比 (OR) 和 95% 置信区间 (CI)。结果：估计有 5,601,382 人因大麻使用障碍住院（初级或二级诊断）。大麻使用障碍住院率（/100,000 人次入院）增加了 3.7 倍，从 1998-2000 年的 439/100,000 人次增至 2013-2014 年的 1,631/100,000 人次入院率。在调整后的分析中，以下因素与大麻使用障碍住院的医疗保健利用结果较差相关：年龄较大； Deyo–Charlson 指数得分为 2 或更高；男性;非私人保险支付人；更高的收入；医院区域；城市医院；以及中型到大型医院病床尺寸。结论：1998 年至 2014 年大麻使用障碍住院率上升令人担忧。我们的研究确定了与大麻使用障碍住院治疗不良利用结果风险较高相关的自变量。医疗保健政策应侧重于减轻大麻使用障碍住院的负担。应针对结果最差的大麻使用障碍高危人群减少相关使用。
Objective: To assess whether cannabis use disorder (abuse or dependence) hospitalizations are increasing over time and examine the variables associated with the outcomes of cannabis use disorder hospitalizations. Methods: This study examined the rates of hospitalizations with cannabis use disorder and associated healthcare utilization using the U.S. National Inpatient Sample data from 1998 to 2014. Adjusted logistic regression analyses assessed the association of demographic, comorbidity and hospital characteristics with healthcare utilization (total hospital charges, length of hospital stays, discharge to a non-home setting) during the index hospitalization for cannabis use disorder. Odds ratio (OR) and 95% confidence intervals (CI) were calculated. Results: There were an estimated 5,601,382 hospitalizations with cannabis use disorder (primary or secondary diagnosis). The rates of hospitalization (/100,000 admissions) for cannabis use disorder increased 3.7-fold from 439/100,000 admissions in 1998–2000 to 1,631/100,000 admissions in 2013–2014. In the adjusted analysis, the following factors were associated with worse healthcare utilization outcomes for cannabis use disorder hospitalizations: older age; Deyo–Charlson index score of 2 or higher; male sex; insurance payer other than private; higher income; hospital region; an urban hospital; and a medium to large hospital bed size. Conclusions: Rising hospitalization rate with cannabis use disorder from 1998 to 2014 is concerning. Our study identified independent variables associated with a higher risk of poor utilization outcomes of cannabis use disorder hospitalizations. Healthcare policies should focus on reducing the burden of cannabis use disorder hospitalizations. High-risk groups of people with cannabis use disorder with the worst outcomes should be targeted to reduce associated utilization.
影响因子：
4.2
作者：
Winters, Ken C.;Lee, Chih-Yuan S.
通讯作者：
Lee, Chih-Yuan S.